Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Conexeu Sciences Inc.CNXU · Entity 6454 | 10% owner | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Conexeu Sciences Inc.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectN3GU Investments LLC | 2,148,048 |
Reported balance
After 2026-06-18 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-06-18 · Exercise / conversion · Acquired 250,000 · Balance 2,148,048 F1: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power. |
| Performance WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2030-06-05 | IndirectN3GU Investments LLC | 250,000 |
Reported balance
After 2026-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-18 · Exercise / conversion · Disposed 250,000 · Balance 250,000 F2: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 650,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration. F1: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power.
F2: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 650,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 17:25 UTC | Conexeu Sciences Inc. CNXU · Entity 6454 | Exercise / conversionPerformance Warrants · Derivative | 250,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002137182-26-000003 · primary_doc.xml · derivative · entry 2 Wright Michael G. · CIK 0002137182 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · N3GU Investments LLC Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2030-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 650,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration. F2 · derivative.exercise_date: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 650,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration. F2 · balance_after: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 650,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration. F1 · ownership.nature: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 17:25 UTC | Conexeu Sciences Inc. CNXU · Entity 6454 | Exercise / conversionCommon Stock | 250,000 | $0.00 | $250.00 |
DisclosureSEC source: 0002137182-26-000003 · primary_doc.xml · nonDerivative · entry 1 Wright Michael G. · CIK 0002137182 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · N3GU Investments LLC Disclosed balance after: 2,148,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power. Read SEC document |
| May 26, 2026 Filed May 28, 2026 15:39 UTC | Conexeu Sciences Inc. CNXU · Entity 6454 | Exercise / conversionPerformance Warrants · Derivative | 400,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002137182-26-000002 · primary_doc.xml · derivative · entry 2 Wright Michael G. · CIK 0002137182 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · N3GU Investments LLC Disclosed balance after: 500,000 Underlying: Common Stock · 400,000 shares Expires 2030-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 400,000 Performance Warrants have vested. The remainder of the Performance Warrants will vest and be exercisable upon the following milestone events: (i) 250,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of >$80,000,000 in the currency of the recognized stock exchange in North America on which the shares of common stock are listed; and (ii) 250,000 Performance Warrants upon the Issuer's submitting a 510(k) application to the United States Food and Drug Administration. F2 · derivative.exercise_date: 900,000 Performance Warrants were granted on June 5, 2025. The Performance Warrants were granted for services rendered to the Issuer and no price was paid for the Performance Warrants. 400,000 Performance Warrants have vested. The remainder of the Performance Warrants will vest and be exercisable upon the following milestone events: (i) 250,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of >$80,000,000 in the currency of the recognized stock exchange in North America on which the shares of common stock are listed; and (ii) 250,000 Performance Warrants upon the Issuer's submitting a 510(k) application to the United States Food and Drug Administration. F1 · ownership.nature: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power. Read SEC document |
| May 26, 2026 Filed May 28, 2026 15:39 UTC | Conexeu Sciences Inc. CNXU · Entity 6454 | Exercise / conversionCommon Stock | 400,000 | $0.00 | $400.00 |
DisclosureSEC source: 0002137182-26-000002 · primary_doc.xml · nonDerivative · entry 1 Wright Michael G. · CIK 0002137182 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · N3GU Investments LLC Disclosed balance after: 1,898,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.